Phase II study of troglitazone as antineoplastic differentiation therapy in patients with malignant liposarcoma
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Troglitazone (Primary)
- Indications Liposarcoma
- Focus Therapeutic Use
- 13 Feb 2017 Biomarkers information updated
- 27 Sep 2005 New trial record.